Exercise for High Blood Sugar During Pregnancy
(TtM Trial)
Trial Summary
What is the purpose of this trial?
This randomized controlled crossover trial of 36 pregnant individuals with gestational diabetes (GDM) or gestational glucose intolerance (GGI) will: 1. Determine the effects of physical activity (PA) timing, specifically 30 minutes of moderate intensity walking or stepping in the morning (between 5am-9am, within 30-40 minutes of starting breakfast), versus late afternoon/evening (between 4pm-8pm, within 30-40 minutes of dinner) on glucose across the 24-hour cycle. 2. Explore the potential effects of the timing of PA on sleep and mood state.
Will I have to stop taking my current medications?
The trial requires that participants not be on daily medications that alter insulin resistance or metabolic profiles, such as metformin, corticosteroids, or anti-psychotics. If you are taking these medications, you would need to stop them to participate.
What data supports the effectiveness of the treatment Moderate intensity walking or stepping, Moderate intensity walking, Stepping exercise for high blood sugar during pregnancy?
Is moderate-intensity exercise safe during pregnancy?
How does exercise differ from other treatments for high blood sugar during pregnancy?
Exercise is a unique treatment for high blood sugar during pregnancy because it can improve glucose tolerance and reduce the need for insulin by using muscle contractions to help transport glucose. Unlike traditional treatments that rely on diet or insulin, exercise can be tailored to individual needs and is safe for both the mother and fetus when done moderately.57111213
Research Team
Samantha Ehrlich, PhD
Principal Investigator
The University of Tennessee, Knoxville
Eligibility Criteria
This trial is for pregnant individuals aged 18-40 with gestational diabetes or glucose intolerance, carrying a single baby without significant abnormalities. Participants must have been diagnosed after 24 weeks of pregnancy and be comfortable communicating in English without a translator.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a randomized crossover trial involving 30 minutes of moderate intensity walking or stepping at specified times over an 11-day period.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Moderate intensity walking or stepping
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
University of Tennessee Graduate School of Medicine
Collaborator